Transcatheter Aortic Valve Replacement in a Pediatric Patient With a History of Congenital Heart Disease and Recent Post-Procedure Decompensation

ALTHOUGH TRANSCATHETER aortic valve replacement (TAVR) with a bioprosthetic valve became a treatment option for calcific aortic stenosis (AS) in select adult patients in 2002, there is less experience with implantation in pediatric patients with a history of congenital heart disease (CHD) and coexisting aortic valve pathology.1,2 Although surgical repair remains the treatment of choice for primary aortic insufficiency (AI) in adults, TAVR feasibility has been demonstrated in select high-risk patients.

Source: Journal of Cardiothoracic and Vascular Anesthesia - June 11, 2020 Category: Anesthesiology Authors: Adam R. McKinney, Jacob B. Meers Tags: Case Report Source Type: research